The Role of Epigenetics in the Progression of Non-Alcoholic Fatty Liver Disease

Author(s): Nancy Edith Aguilar-Olivos, Jesús Oria-Hernández, Guadalupe Ponciano-Rodríguez, Norberto Carlos Chávez-Tapia, Misael Uribe, Nahum Méndez-Sánchez

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 15 , Issue 14 , 2015

Become EABM
Become Reviewer
Call for Editor


Non-alcoholic fatty liver disease encompasses a spectrum of pathologies ranging from simple steatosis to non-alcoholic steatohepatitis. Patients with non-alcoholic steatohepatitis have increased risk of cirrhosis, liver failure and hepatocellular carcinoma. About 25% of subjects with simple steatosis progress to steatohepatitis; nowadays, the detailed pathological factors influencing the progression of non-alcoholic fatty liver disease remains unclear. It is proposed that genetic and environmental factors interact to determine the disease phenotype. Epigenetics could explain some relationships between genes and external influences. The epigenetic changes that have been related to non-alcoholic fatty liver disease are DNA methylation, onecarbon metabolism, histone modifications and the presence of micro-RNA. DNA methylation and micro-RNAs have been investigated in human samples, whereas histone modifications have only been studied until now in animal and cellular models. The aim of this study is to review the most relevant information about epigenetic changes in non-alcoholic steatohepatitis.

Keywords: Biological markers, disease progression, DNA methylation, histones, liver, microRNAs, one-carbon metabolism.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [1187 - 1194]
Pages: 8
DOI: 10.2174/1389557515666150709115702
Price: $65

Article Metrics

PDF: 50